|224.88||+10.08||+4.69%||Vol 527.38K||1Y Perf -57.58%|
|Aug 10th, 2022 13:41 DELAYED|
|4.02 1.87%||- -|
|Target Price||328.70||Analyst Rating||Hold 2.56|
|Potential %||46.38||Finscreener Ranking||★★★+ 51.04|
|Insiders Trans % 3/6/12 mo.||-100/-100/-100||Value Ranking||★★★ 50.59|
|Insiders Value % 3/6/12 mo.||-100/-100/-100||Growth Ranking||★★★★★ 66.87|
|Insiders Shares Cnt. % 3/6/12 mo.||-100/-100/-100||Income Ranking||— -|
|Price Range Ratio 52W %||14.59||Earnings Rating||Strong Sell|
|Market Cap||35.33B||Earnings Date||11th Aug 2022|
Today's Price Range
5 Year PE Ratio Range
|Earnings History||Estimate||Reported||Surprise %|
|Earnings Per End||Estimate||Revision %||Trend|
|Next Report Date||11th Aug 2022|
|Estimated EPS Next Report||0.63|
|EPS Growth Next 5 Years %||31.20|
|Avg. Weekly Volume||884.11K|
|Avg. Monthly Volume||1.06M|
|Avg. Quarterly Volume||1.34M|
Illumina Inc. (NASDAQ: ILMN) stock closed at 214.8 per share at the end of the most recent trading day (a -3.67% change compared to the prior day closing price) with a volume of 802.91K shares and market capitalization of 35.33B. Is a component of S&P 500, NASDAQ 100, Russell 1000 indices and it is traded on NASDAQ exchange. The company belongs in the Medical Diagnostics & Research industry, Healthcare sector and employs 7850 people. Illumina Inc. CEO is Francis A. DeSouza.
The one-year performance of Illumina Inc. stock is -57.58%, while year-to-date (YTD) performance is -43.54%. ILMN stock has a five-year performance of 10.35%. Its 52-week range is between 173.45 and 526, which gives ILMN stock a 52-week price range ratio of 14.59%
Illumina Inc. currently has a PE ratio of 41.40, a price-to-book (PB) ratio of 2.73, a price-to-sale (PS) ratio of 8.34, a price to cashflow ratio of 67.00, a PEG ratio of 2.32, a ROA of 5.96%, a ROC of 6.96% and a ROE of 9.02%. The company’s profit margin is 14.53%, its EBITDA margin is 25.70%, and its revenue ttm is $3.53 Billion , which makes it $22.47 revenue per share.
Of the last four earnings reports from Illumina Inc., there were 4 positive earnings surprise and 0 negative earnings surprise. The company has EPS estimate of $0.63 for the next earnings report. Illumina Inc.’s next earnings report date is 11th Aug 2022.
The consensus rating of Wall Street analysts for Illumina Inc. is Hold (2.56), with a target price of $328.7, which is +46.38% compared to the current price. The earnings rating for Illumina Inc. stock is Strong Sell (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).
Illumina Inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.
Illumina Inc. has a Neutral technical analysis rating based on Technical Indicators (ADX : 18.60, ATR14 : 9.61, CCI20 : 60.68, Chaikin Money Flow : 0.24, MACD : 5.36, Money Flow Index : 64.25, ROC : 6.50, RSI : 45.23, STOCH (14,3) : 54.24, STOCH RSI : 0.00, UO : 51.23, Williams %R : -45.76), Simple Moving Averages and Exponential Moving Averages.
Aggregated Insider Trades of Illumina Inc. in the last 12-months were: Aimee L. Hoyt (Option Excercise at a value of $0), Aimee L. Hoyt (Sold 2 274 shares of value $798 250 ), Alexander Aravanis (Sold 12 404 shares of value $5 013 237 ), Charles E. Dadswell (Option Excercise at a value of $0), Charles E. Dadswell (Sold 3 202 shares of value $1 325 415 ), Francis A. DeSouza (Option Excercise at a value of $0), Joydeep Goswami (Option Excercise at a value of $0), Kevin Carl Pegels (Option Excercise at a value of $0), Phillip G. Febbo (Option Excercise at a value of $0), Phillip G. Febbo (Sold 2 988 shares of value $1 122 530 ), Sam A. Samad (Option Excercise at a value of $0), Susan H. Tousi (Option Excercise at a value of $0), Susan H. Tousi (Sold 2 250 shares of value $914 497 )
Mon, 18 Jul 2022 03:16 GMT Illumina (ILMN) Gets a Hold Rating from SVB Securities- TipRanks. All rights reserved.
Fri, 20 May 2022 01:10 GMT Illumina (ILMN) Receives a Hold from Credit Suisse- TipRanks. All rights reserved.
Tue, 10 May 2022 12:05 GMT Analysts Offer Insights on Healthcare Companies: Heska (HSKA), Illumina (ILMN) and Owens & Minor (OMI)- TipRanks. All rights reserved.
Sat, 07 May 2022 03:37 GMT Illumina (ILMN) Gets a Hold Rating from Robert W. Baird- TipRanks. All rights reserved.
Wed, 30 Mar 2022 09:07 GMT OTR Global Upgrades Illumina (ILMN) to Buy- TipRanks. All rights reserved.
Thu, 03 Mar 2022 01:10 GMT Illumina (ILMN) was Upgraded to a Hold Rating at Credit Suisse- TipRanks. All rights reserved.
Copyright © 2016-2022 Finscreener.org. All Rights Reserved.
Disclaimer: Before deciding to trade you should carefully consider your investment objectives, level of experience and your risk appetite. Forex and Tradegate data is a real-time with a 30 second refresh. Prices may not be accurate and may differ from the actual market price. Prices on the website are indicative and solely for informational purposes, not for trading purposes or advice. Please be aware of the risks associated with trading the on financial markets, it is one of the riskiest investment forms. Past performance does not guarantee future profits. We take no responsibility for any losses that may arise as a result of the data contained on this website. The content and the website are provided "as is", without any warranties. In no event will Finscreener.org, its employees, owners, directors, affiliates, partners, data provider, third party or anyone else liable to anyone else for any decision made regarding information on this website.
This could take some time, please wait.